1. [177Lu]-PSMA-617 for targeted prostate cancer treatment: a magic bullet?. Issue 6 (June 2018) Authors: Paganelli, Giovanni; De Giorgi, Ugo Journal: Lancet oncology Issue: Volume 19:Issue 6(2018) Page Start: 725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma. (September 2020) Authors: Lolli, Cristian; Altavilla, Amelia; Conteduca, Vincenza; Farolfi, Alberto; Casadei, Chiara; Schepisi, Giuseppe; Banna, Giuseppe Luigi; De Giorgi, Ugo Journal: Critical reviews in oncology/hematology Issue: Volume 153(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A European, prospective, observational study of enzalutamide in patients with metastatic castration‐resistant prostate cancer: PREMISE. Issue 5 (8th November 2021) Authors: Payne, Heather; Robinson, Angus; Rappe, Bernard; Hilman, Serena; De Giorgi, Ugo; Joniau, Steven; Bordonaro, Roberto; Mallick, Stéphane; Dourthe, Louis‐Marie; Flores, Moisés Mira; Gumà, Josep; Baron, Benoit; Duran, Aurea; Pranzo, Alessandra; Serikoff, Alexis; Mott, David; Herdman, Mike; Pavesi, Ma... Journal: International journal of cancer Issue: Volume 150:Issue 5(2022) Page Start: 837 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group. Issue 9 (21st March 2022) Authors: Bartoletti, Michele; Bergamini, Alice; Giannone, Gaia; Nero, Camilla; Musacchio, Lucia; Farolfi, Alberto; Passarelli, Anna; Kuhn, Elisabetta; Castaldo, Daniele; Lombardo, Valentina; Di Palma, Teresa; Lorusso, Domenica; Puglisi, Fabio; De Giorgi, Ugo; Valabrega, Giorgio; Schettino, Clorinda; Scamb... Journal: International journal of gynecological cancer Issue: Volume 32:Issue 9(2022) Page Start: 1205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03). Issue 1 (February 2023) Authors: Procopio, Giuseppe; Claps, Mélanie; Pircher, Chiara; Porcu, Luca; Sepe, Pierangela; Guadalupi, Valentina; De Giorgi, Ugo; Bimbatti, Davide; Nolè, Franco; Carrozza, Francesco; Buti, Sebastiano; Iacovelli, Roberto; Ciccarese, Chiara; Masini, Cristina; Baldessari, Cinzia; Doni, Laura; Cusmai, Antoni... Journal: Tumori Issue: Volume 109:Issue 1(2023) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. (30th January 2015) Authors: Pietri, Elisabetta; Andreis, Daniele; Fabbri, Francesca; Menna, Cecilia; Schirone, Alessio; Kopf, Barbara; Rocca, Andrea; Amadori, Dino; De Giorgi, Ugo Journal: Oncologist Issue: Volume 20:Number 3(2015) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Phase II Study of a Dose‐Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. (30th January 2015) Authors: Pietri, Elisabetta; Andreis, Daniele; Fabbri, Francesca; Menna, Cecilia; Schirone, Alessio; Kopf, Barbara; Rocca, Andrea; Amadori, Dino; De Giorgi, Ugo Journal: Oncologist Issue: Volume 20:Number 3(2015) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer. (25th May 2017) Authors: Lolli, Cristian; Gallà, Valentina; Schepisi, Giuseppe; Barone, Domenico; Burgio, Salvatore Luca; Maugeri, Antonio; Vertogen, Bernadette; Amadori, Dino; De Giorgi, Ugo Journal: Oncologist Issue: Volume 22:Number 7(2017) Page Start: 784 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer. (July 2017) Authors: Lolli, Cristian; Gallà, Valentina; Schepisi, Giuseppe; Barone, Domenico; Burgio, Salvatore Luca; Maugeri, Antonio; Vertogen, Bernadette; Amadori, Dino; De Giorgi, Ugo Journal: Oncologist Issue: Volume 22:Number 7(2017) Page Start: 784 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia. Issue 1 (January 2020) Authors: Cerchione, Claudio; Martinelli, Giovanni; Pedatella, Silvana; De Nisco, Mauro; Pugliese, Novella; Manfra, Michele; Marra, Nicoletta; Ronconi, Sonia; De Giorgi, Ugo; Altini, Mattia; Simonetti, Giorgia; Di Rorà, Andrea Ghelli Luserna; Bravaccini, Sara; Catalano, Lucio; Dora Iula, Vita; Pagano, Fran... Journal: Anti-cancer drugs Issue: Volume 31:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗